The Dexcom G6 uses a small, wearable sensor and transmitter, now indicated to be placed on the back of the upper arm, to continuously measure and send glucose levels wirelessly to a dedicated receiver or compatible smart device, removing the need for fingerpricks. The system also includes customizable alerts and alarms.
Dexcom designed its CGM to address consumer convenience, as the system has a 10-day sensor, easy-to-use applicator and it does not require calibration.
The Dexcom G6 is available for patients in Europe over the age of two and can be worn on the abdomen, as well as on the back of the upper arm. Patients up to 17 can wear the device on the upper buttocks as well.
“We are excited that the Dexcom G6 has received CE Marking in Europe for wear on the back of the upper arm,” Dexcom senior VP & GM for EMEA Erik Bjorkman said in a news release. “It is a breakthrough development for all Dexcom G6 users, and highlights our continued mission to innovate and improve diabetes management on behalf of everyone living with diabetes. It is our hope to inspire confidence within our community and in one another.”